期刊
ONCOTARGET
卷 7, 期 23, 页码 35490-35496出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.8204
关键词
myeloid-derived suppressor cells; Th17 cells; tumor; autoimmunity; cytokine
资金
- National Science Foundation for Outstanding Young Scholars of China [81522006]
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China [81470527, 81270323]
- Zhejiang Provincial Outstanding Youth Foundation [LR13H020001]
Myeloid-derived suppressor cells (MDSCs) and Th17 cells were first discovered in the fields of cancer and autoimmunity, respectively. In recent years, their activities have been explored in other biological and pathological conditions, such as infective diseases and solid organ transplantation. However, the interplay between MDSCs and Th17 cells and the mechanism of their interaction remain obscure. This review summarized and analyzed the relationship between MDSCs and Th17 cells, both of which participate in tumor, autoimmune disease, infection and other conditions. In tumors, the increase in MDSCs at the tumor site is usually accompanied by the accumulation of Th17 cells. However, their relationship is inconsistent in different tumors. In arthritic mice or rheumatoid arthritis (RA) patients, an increase in MDSCs, which could ameliorate disease symptoms, causes decreased IL-17A gene expression and Th17 cells accumulation. Furthermore, we concluded that the interaction between MDSCs and Th17 cells is mainly mediated by cytokines. However, the mechanisms require further investigation. Determining the details of their interplay will provide a better understanding of immune networks and could lead to the development of immunotherapeutic strategies in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据